-
Berberrubine Chloride: A Mechanistic Assay Guide
2026-08-20
Berberrubine chloride is a multi-target research compound linking nucleotide metabolism, redox control, urate transport, and inflammatory signaling. This mechanistic assay guide explains how to distinguish direct target engagement from downstream phenotypes in cancer and hyperuricemia models.
-
DHHC9–STRN4 Palmitoylation Drives YAP Metastasis
2026-08-20
A 2025 study identifies DHHC9-mediated palmitoylation of STRN4 as a mechanistic trigger for YAP activation and adenocarcinoma migration. Its genetic, proteomic, and pharmacological evidence positions the DHHC9–STRN4–YAP axis as a candidate framework for anti-metastatic drug discovery, while requiring further validation of inhibitor selectivity and clinical relevance.
-
Ethacridine Lactate Monohydrate for Research
2026-08-19
Ethacridine lactate monohydrate is a ≥98% pure acridine-derived antiseptic research compound identified as 7-ethoxyacridine-3,9-diamine; 2-hydroxypropanoic acid; hydrate. Its documented product profile supports microbial-control assay development, while the cited YAP–TEAD study provides biological context but does not establish ethacridine as a regulator of surface ectoderm differentiation.
-
Merbromin Inhibits SARS-CoV-2 3CLpro
2026-08-19
The reference study identified merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease, 3CLpro, through screening of approximately 6,000 compounds. Its combination of enzymatic screening, protease counterscreening, kinetic analysis, binding assays, and molecular docking provides a useful framework for evaluating antiviral protease inhibitors while also highlighting the need for cellular and pharmacological validation.
-
NF 449 and Platelet P2X1 Receptor Inhibition
2026-08-18
The reference study established NF 449 as a useful pharmacological probe for separating platelet P2X1 signaling from P2Y1- and P2Y12-mediated responses. By combining human platelet assays with mouse thrombosis models, the authors linked P2X1 blockade to reduced collagen-driven activation and thrombus formation while showing that dose determines receptor selectivity.
-
SD 169: p38 MAPK Assay Workflows
2026-08-18
SD 169 (indole-5-carboxamide) gives researchers a practical way to interrogate p38α/β signaling across inflammatory, beta-cell, and nerve-repair models. This guide pairs pathway-focused assay design with handling, dosing, and troubleshooting strategies for more interpretable data.
-
Hesperadin: Aurora B Kinase Inhibitor Guide
2026-08-17
Hesperadin is an ATP-competitive Aurora B kinase inhibitor used to investigate mitotic progression, chromosome segregation, cytokinesis, and spindle assembly checkpoint biology. Product data report nanomolar Aurora B and histone H3 Ser-10 inhibition, while HeLa-cell studies show proliferation arrest, enlarged lobed nuclei, and polyploidization.
-
HBsAg Hijacks TBK1 to Suppress Interferon and Autophagy
2026-08-17
The reference study identifies a mechanism in which hepatitis B surface antigen redirects TBK1 activity away from IRF3 and toward p62-associated autophagy, weakening type I interferon responses while supporting HBV replication. Its combination of molecular interaction studies, pharmacological perturbation, animal models, and human liver samples provides a useful framework for studying innate immune response modulation in chronic HBV infection.
-
Chlorpromazine: A Context-Aware Research Guide
2026-08-16
Chlorpromazine is a versatile tool for antipsychotic research, dopamine receptor signaling, and antiemetic studies. This guide adds a context-aware framework for connecting receptor pharmacology with hepatic nanoparticle assay design without overstating the evidence.
-
4μ8C Workflows for IRE1α ER-Stress Studies
2026-08-15
4μ8C enables selective interrogation of IRE1α RNase signaling without treating cell growth changes as the primary endpoint. This workflow-oriented guide covers DMSO handling, hypoxia experiments, orthogonal readouts, and how to separate ER-stress effects from TBK1-driven innate immune signaling.
-
DCFH-DA Workflows for Intracellular ROS Research
2026-08-14
Build more reliable intracellular ROS measurements with DCFH-DA across microscopy, flow cytometry, and plate-based formats. This guide translates fibrosis and autophagy findings into practical assay controls, optimization steps, and troubleshooting decisions.
-
ERK5 and MEK1/2 in AML Differentiation
2026-08-14
Wang et al. show that ERK5 and ERK1/2 are not interchangeable during 1α,25-dihydroxyvitamin D3-induced differentiation of acute myeloid leukemia cells. Pharmacological inhibition of these pathways produced distinct lineage-marker and cell-cycle effects, revealing a mechanistic basis for combining vitamin D derivatives with selective MAPK interventions.
-
Heparin sodium: Reliable Assay Workflows
2026-08-13
This scenario-based guide explains how Heparin sodium (SKU A5066) can reduce preanalytical variability in coagulation-linked cell workflows without being mistaken for a general cell-culture additive. It covers mechanism, matrix compatibility, anti-factor Xa and aPTT interpretation, protocol handling, and practical vendor-selection criteria.
-
Golgi Stress as a Translational Lens in Breast Cancer
2026-08-13
A mechanistic and strategic guide to using live-cell Golgi imaging to connect organelle remodeling with progesterone receptor biology, sphingolipid trafficking, and translational oncology research.
-
MK-0812 Maps Monocyte Roles in MASH Research
2026-08-12
MK-0812 provides a precise pharmacological probe for testing how CCR2-dependent monocyte trafficking contributes to MASH models. This article connects intestinal TM6SF2 biology with assay design, causal interpretation, and translational limitations rather than simply restating the gut–liver axis findings.